Cediranib maleate (Synonyms: 西地尼布马来酸盐; AZD-2171 maleate)
目录号: PL09033 纯度: ≥99%
CAS No. :857036-77-2
商品编号 规格 价格 会员价 是否有货 数量
PL09033-5mg 5mg ¥741.82 请登录
PL09033-10mg 10mg ¥1112.73 请登录
PL09033-50mg 50mg ¥3956.36 请登录
PL09033-100mg 100mg ¥6429.09 请登录
PL09033-200mg 200mg 询价 询价
PL09033-500mg 500mg 询价 询价
PL09033-10mM*1mLinDMSO 10mM*1mLinDMSO ¥924.80 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
Cediranib maleate
中文别名
西地尼布马来酸盐
英文名称
Cediranib maleate
英文别名
(Z)-but-2-enedioic acid,4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline;AZD 2171 maleate;AZD-2171 maleate;[14C]-Cediranib maleate;4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline maleate;Cediranib maleate;Cediranib maleate [USAN:JAN];Recentin;UNII-68AYS9A614;AZD 2171 maleate; Cediranib maleate; Recentin
Cas No.
857036-77-2
分子式
C25H27N4O3F.C4H4O4
分子量
566.58
包装储存
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
产品详情
Cediranib maleate (AZD-2171 maleate) 是高选择性,有口服活性的 VEGFR2 抑制剂,对Flt1,KDR,Flt4,PDGFRα,PDGFRβ,c-Kit的 IC50 值分别为小于1, 小于3,5,5,36,2nM。
生物活性
Cediranib maleate (AZD-2171 maleate) is a highly potent, orally available VEGFR inhibitor with IC 50 s of <1, <3, 5, 5, 36, 2 nM for Flt1, KDR, Flt4, PDGFRα, PDGFRβ, c-Kit, respectively.
性状
Solid
IC50 & Target[1][2]
Flt-1 5 nM (IC50) KDR 1 nM (IC50
体外研究(In Vitro)
In human umbilical vein endothelial cells, Cediranib inhibits VEGF-stimulated proliferation and KDR phosphorylation with IC50 values of 0.4 and 0.5 nM, respectively. In a fibroblast/endothelial cell coculture model of vessel sprouting, Cediranib also reduces vessel area, length, and branching at subnanomolar concentrations. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
Once-daily oral administration of Cediranib ablates experimental (VEGF-induced) angiogenesis and inhibits endochondral ossification in bone or corpora luteal development in ovary; physiologic processes that are highly dependent upon neovascularization. The growth of established human tumor xenografts (colon, lung, prostate, breast, and ovary) in athymic mice is inhibited dose-dependently by Cediranib, with chronic administration of 1.5 mg per kg per day producing statistically significant inhibition in all models. A histologic analysis of Calu-6 lung tumors treated with Cediranib reveals a reduction in microvessel density within 52 hours that becomes progressively greater with the duration of treatment. These changes are indicative of vascular regression within tumors. has not independently confirmed the accuracy of the
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
ClinicalTrial
参考文献
[1]. Wedge SR, et al. AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer. Cancer Res, 2005, 65(10), 4389-4400.
溶解度数据
In Vitro: DMSO : ≥ 45 mg/mL (79.42 mM)H2O : 2 mg/mL (3.53 mM; Need ultrasonic)
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2